Skip to main content

The U.S. Trade Representative’s Office on Monday will begin a week of testimony about President Donald Trump’s plan for additional tariffs on China.

Jose Luis Magana/The Associated Press

The U.S. Trade Representative’s Office on Monday will kick off seven days of testimony from U.S. retailers, manufacturers and other businesses about President Donald Trump’s plan to hit another $300 billion worth of Chinese goods with tariffs.

The hearings beginning Monday will end on June 25, the USTR said in a statement on Friday. That timeline means Trump would not be able to trigger the fresh wave of tariffs until after July 2, when a seven-day final rebuttal comment period ends.

U.S.-China relations have deteriorated since Trump accused Beijing in early May of reneging on commitments to change its ways of doing business with the rest of the world.

Story continues below advertisement

Since then, Trump raised tariffs to 25 per cent on $200 billion of Chinese goods and ordered his trade representative to prepare tariffs on another $300 billion, effectively covering almost all Chinese exports to the United States.

Trump has said he wants to meet with Chinese President Xi Jinping during June 28-29 G20 leaders summit in Japan, but neither government has confirmed a meeting.

The proposed tariffs on another $300 billion are a further “response to China’s unfair trade practices related to technology transfer, intellectual property, and innovation,” USTR said in its statement Friday.

The tariffs will hit consumer goods hard, including cellphones, laptop computers, toys, video game consoles, television sets, clothing and footwear.

The list of more than 300 scheduled witnesses includes representatives from retailer Best Buy, toy maker Hasbro Inc vacuum cleaner maker iRobot, faucet maker Moen and other firms and trade groups in a diverse range of industries.

Related topics

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter